StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
Equities research analysts at StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the stock. A number of other equities analysts also recently issued reports on CANF. HC Wainwright reiterated a “buy” rating and set […]
Equities research analysts at StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the stock. A number of other equities analysts also recently issued reports on CANF. HC Wainwright reiterated a “buy” rating and set […]
